Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2020
Kodiak Sciences announces public stock offering
Kodiak Sciences announced the pricing of an underwritten public offering of 5,193,237 common shares at $108 per share, with gross proceeds expected to be approximately $560.9 million. The offering was expected to close on or about November 20, 2020, subject to customary closing conditions.
2020
Kodiak Sciences appoints Charles Bancroft to its board
Kodiak Sciences announced the appointment of Charles Bancroft to its board of directors.
2019
Kodiak Sciences appoints Taiyin Yang to its board
Kodiak Sciences announced the appointment of Taiyin Yang, Ph.D., to its board of directors.
2019
Kodiak Sciences prices public stock offering
Kodiak Sciences announced the pricing of an underwritten public offering of 6,000,000 common shares at $46 per share, with expected gross proceeds of approximately $276 million before expenses.
2019
Kodiak Sciences announces $225 million royalty funding for KSI-301
Kodiak Sciences announced a funding agreement to sell Baker Bros. Advisors a capped royalty right on global net sales of KSI-301 for $225 million in committed development funding. The first $100 million was expected at transaction closing on January 10, 2020, with the remaining $125 million contingent on specified conditions.